ENVX Company Profile and Key Details

ENVX has shown weak momentum, losing -12.98% over the past week and -26.68% over the past quarter, though year-to-date performance is down -32.75%. Short-term trend indicators are bullishly aligned (SMA20 -10.84%, SMA50 -18.43%, SMA200 -22.62%). The stock’s 14-day RSI is 39.2 (weak momentum), while the ATR of 0.54 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -55.67% below its high and over 38.71% above its low. Average 10-day trading volume of 4.86 million shares is below the 3-month average of 7.19 million, indicating normal recent market interest.

Enovix Corporation (NASDAQ:ENVX) closed at $7.31 USD, losing -$0.11 (-1.42%) from the previous close of $7.42. The stock is currently mid-range between its 52-week high and low $5.27 and $16.49. With a market capitalization of about $1.40 billion, Enovix Corporation is classified as a small-cap and shows higher-than-market volatility (beta ~2.12). Key stats such as the average daily volume over the past year has been around 7.28 million shares, volume is running light vs its 52-week average. Headquartered in Fremont, CA, Enovix Corporation operates in the Industrials sector and the Electrical Equipment & Parts industry. Led by CEO Raj Talluri, the company employs approximately 570 people and listed since January 05, 2021. Enovix Corporation designs, develops, and manufactures lithium-ion batteries.

Enovix Corporation has 196.60 million shares outstanding. The public float is 172.95 million shares, elevated short interest at 29.07% of float. This equals 42.95 million shares. The short ratio is 4.08 days. Institutional investors hold 53.63% of the float. Insiders own 12.81%. Park West Asset Management LLC holds 6.44 million shares, RUST HARROLD J has 1.37 million shares and Lahiri Ashok has 1.36 million shares. Over the past six months, insider transactions show net selling. They sold 2.10 million shares across 9 transactions.

Enovix Corporation generated EPS of -$0.81 over the past year. Five-year average earnings growth is 2.05%. Wall Street analysts project EPS growth of 21.03% annually over the next five years. The latest quarter delivered EPS of -$0.14. The next quarter is forecast at -$0.18. Next year's EPS is expected at $1.59. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 7 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $30.00 to $10.00. The high target offers 310.4% upside. The low target suggests 36.8% downside. The mean target is $18.82. This offers 157.46% upside. Enovix Corporation earnings surprise history is frequent misses against expectations. The quarter that ended November 05, 2025, missed forecasts by -12.5%. The prior quarter beat by -13.33%. Over the last six quarters, Apple has recorded several small beats. These include -36.36% in July 31, 2024.

Enovix Corporation last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$2.61. This means the shares are trading below this model’s fair value.

Enovix Corporation trades at a P/E ratio of -9.39, slightly below the S&P 500 average, with a price-to-sales ratio of 45.85 and a price-to-book ratio of 5.08 trading at moderately above to book value. The P/FCF stands at -11.78, also below market averages.

Our AI price prediction model suggests that Enovix Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.6%, with price expected at $7.50 by January 14, 2026, within a range of $6.76 to $8.25 3-Month Outlook: Projected fall of -49.66%, reaching $3.68 by March 30, 2026, with a range of $3.32 to $4.03. 1-Year Outlook: Projected gain of 120.93%, with price at $16.15 by December 31, 2026, within a range of $3.24 to $26.48.

Enovix Corporation (NASDAQ:ENVX) shares are down -32.75% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Enovix Corporation trading at a premium to the broader market with a P/E of -9.39. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $25.25, suggesting 245.42% upside. Our AI forecast model points to short-term strength (2.6% over two weeks), a medium-term fall (-49.66% over three months), and a longer-term gain (120.93% over one year), with expected trading ranges indicating moderate volatility.